Skip to main content

Opko to Buy Chilean Drug Firm for $16M in Cash

Premium

Opko Health last week announced that it has signed a definitive agreement to acquire Pharma Genexx, a privately held Chilean pharmaceutical firm, for $16 million in cash.

According to Opko, Pharma Genexx focuses on "the representation, importation, commercialization, and distribution of pharmaceutical products, [over-the-counter] products, and medical devices for the government, private, and institutional markets."

"We believe this acquisition to be an excellent strategic fit for Opko as we broadly expand into international markets," Opko Chairman and CEO Phillip Frost said in a statement. "We plan to extend the range of therapeutic areas covered by our products while maintaining a position in ophthalmology."

Additional terms of the transaction were not disclosed.

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.